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234 The Journal of Thoracic and Cardbjective: Aortic valve replacement in patients with a small aortic annulus is often
ssociated with increased pressure gradients. For this reason, prostheses for com-
letely supra-annular placement have been developed. To evaluate the potential
enefit of this design, the present study compared the effectiveness of 1 intra–supra-
nnular bioprosthesis and 3 completely supra-annular bioprostheses in patients with
n aortic annulus diameter of 23 mm or less.
ethods: Between August 2000 and December 2004, each of 192 patients requiring
ortic valve replacement with an intraoperatively measured aortic annulus diameter
f 23 mm or less received one of the following bioprostheses: the stented bovine
orin Soprano bioprosthesis (n  28) (Sorin Group, Saluggia, Italy), the Carpen-
ier–Edwards Perimount bioprosthesis (n  50) (Edwards Lifesciences, Irvine,
alif), the Carpentier–Edwards Perimount Magna bioprosthesis (n  70) (Edwards
ifesciences), or the stented porcine Medtronic Mosaic (n  44) (Medtronic Inc,
inneapolis, Minn) bioprosthesis. After 6 months, hemodynamic data at rest and
uring exercise were obtained by echocardiography in 142 patients.
esults: The pericardial valves showed lower mean systolic pressure gradients,
arger effective orifice areas and indices, and superior effective orifice fractions than
id the porcine valve (P  .05) (Carpentier–Edwards Perimount: 10.9  3.6 mm
g, 1.59  0.41 cm2, 0.9  0.25 cm2/m2, 41.9%  9.6%; Carpentier–Edwards
erimount Magna 10.1 3.8 mm Hg, 1.64 0.38 cm2, 0.93 0.22 cm2/m2, 45.1%
10.2%; Sorin Soprano 13.5 5.0 mm Hg, 1.64 0.32 cm2, 0.92 0.15 cm2/m2,
5.8%  9.0%; vs Medtronic Mosaic 15.5  5.2 mm Hg, 1.31  0.42 cm2, 0.75 
.24 cm2/m2, 35.2%  10.0%, respectively). The lowest mean systolic pressure
radients were found after the implantation of the Carpentier–Edwards Perimount
agna. Effective orifice areas, indices, and fractions of the pericardial valves did
ot show significant differences.
onclusions: In patients with small aortic roots, transvalvular gradients and effec-
ive orifice area showed a tendency to superior results in pericardial valves com-
ared with the porcine bioprosthesis. However, the completely supra-annular design
oes not necessarily lead to superior hemodynamic results compared with the
ntra–supra-annular position.
ven with the most sophisticated design of prostheses for aortic valve replace-
ment, a residual pressure gradient may remain, especially in patients with a
small aortic annulus or aortic root.
A new concept for optimizing hemodynamic performance is the construction of
rostheses that are designed for completely supra-annular implantation. The stent
aterial of completely supra-annular valves is placed on top of the sewing ring.
entriculoarterial mattress sutures combined with the new design theoretically
iovascular Surgery ● May 2007
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CDnsure that stent and sewing ring material do not reach the
utflow tract, thus impairing the flow of blood. This design
as first implemented in the Medtronic Mosaic (Medtronic
nc, Minneapolis, Minn) bioprosthesis, followed by the
arpentier–Edwards Perimount Magna (Edwards Life-
ciences, Irvine, Calif) and Sorin Soprano (Sorin Group, Sa-
uggia, Italy) bioprostheses.
This study evaluates the systolic pressure gradients and
ffective orifice areas (EOA) of these valves in patients with
small aortic annulus at rest and during exercise, and
nalyzes the potential hemodynamic benefit resulting from
ompletely supra-annular placement. As a reference valve
ith an intra–supra-annular design, the Carpentier–Edwards
erimount (Edwards Lifesciences) pericardial prosthesis
as included.
For hemodynamic comparisons of different tissue pros-
heses, the labeled valve sizes may not be suitable, because
here is a discrepancy between geometric dimensions and
alve size labeling by different companies.1-4 The bias that
s caused by using the labeled valve size can be avoided by
sing an independent index for all valve types, which refers
o the intraoperatively measured aortic annulus area and the
alve’s hemodynamic performance. The independent index
e use is the effective orifice fraction (EOF), which was
reviously introduced by our group.3
aterials and Methods
ioprostheses
he Carpentier–Edwards Perimount (Perimount) valve is a stented
ovine pericardial bioprosthesis for intra–supra-annular implanta-
ion. It received Food and Drug Administration approval in 1991.
igh rates of freedom from valve-related adverse events have been
hown in long-term studies.5
The Carpentier–Edwards Perimount Magna (Magna) valve is a
tented bovine pericardial bioprosthesis. The valve corresponds to
he Perimount in terms of tissue preparation and prosthetic mate-
ial, but it has been modified to permit completely supra-annular
lacement. In addition, this valve has a reduced sewing ring. The
agna prosthesis has been in clinical use since September 2002.
The Medtronic Mosaic (Mosaic) valve is a stented porcine
ioprosthesis. It has been in clinical use in Europe since 1994 and
n the United States since 2000 and has exhibited high rates of
reedom from adverse events in midterm follow-up studies.6-8
The Sorin Soprano (Soprano) valve is a stented bovine bio-
Abbreviations and Acronyms
EOA  effective orifice area
EOAI  effective orifice area index
EOF  effective orifice fraction
LVOT left ventricular outflow tract
PPM  patient–prosthesis mismatch
VTI  velocity time integralrosthesis. In terms of tissue preparation and prosthetic material, it fi
The Journal of Thoracicorresponds to the Sorin Pericarbon More, which has been in
linical use for more than 15 years9 but differs in stent design. It
s designed to permit completely supra-annular implantation to
mprove hemodynamic performance. It has been in clinical use
ince August 2003.
urgical Procedure and Measurement of the Aortic
nnulus With a Universal Metric Sizer
ortic valve replacement was performed using standard cardio-
ulmonary bypass with moderate hypothermia at 32°C with cold
rystalloid cardioplegic cardiac arrest. After removal of the native
ortic valve and decalcification of the aortic annulus and root, the
nternal diameter of the aortic annulus was routinely measured by
nserting a probe (Hegar dilator) into the annulus (unit: 1 mm).
ith the assumption that the aortic annulus approaches a circular
hape, the annulus orifice area was calculated as follows: (Hegar
ilator’s diameter [cm] 0.5)2. The prosthetic valve size was
etermined by using the original sizer provided by each manufac-
urer. All bioprostheses were implanted with pledgeted, inter-
upted, non-everting mattress sutures.
ompletely Supra-annular Placement
ompletely supra-annular placement is achieved by using ven-
riculoarterial mattress sutures combined with the new valve de-
ign, in which the stent is placed on top of the sewing ring and not
eside the sewing ring.
atient Enrollment and Follow-up
etween August 2000 and December 2004, 192 patients with an
ortic stenosis or combined aortic lesion diagnosis requiring valve
eplacement entered the study. Only patients with an intraopera-
ively measured aortic annulus diameter of 23 mm or less were
ncluded in this prospective, nonrandomized study, irrespective of
he labeled valve size of the implanted prosthesis. Fifty patients
eceived the Perimount valve, 70 patients received the Perimount
agna valve, 44 patients received the Mosaic valve, and 28
atients received the Soprano valve. At our institution, the 4 tested
alves were not all on hand at the same time during the whole
eriod of the study. The Mosaic and Perimount valves have been
sed since August 2000. They were followed by the Magna in
anuary 2001 and the Soprano in September 2003. We included the
atients consecutively to avoid bias by patient selection; the con-
equence is the variance in group size. The valve type was chosen
ccording to the surgeon’s preference. All patients gave informed
onsent to participate in the study. The study was approved by the
ocal ethics committee. Concomitant procedures were allowed,
xcept for valve replacement in another position. Patients requiring
alve replacement for acute endocarditis or emergency cases were
ot included in the study. Body surface area, aortic annulus diam-
ter, and patient age and gender at the time of operation are
ummarized in Table 1. There is no significant difference between
he groups.
Hemodynamic data obtained 6 months postoperatively during
est and mild physical exercise on a bicycle ergometer were
vailable in 142 patients.
The reasons for nonattendance at the follow-up examination are
iven in Table 2. There is no difference between the groups who
nally underwent the stress test (Table 3).
and Cardiovascular Surgery ● Volume 133, Number 5 1235
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A
CDchocardiographic Measurements and Calculations
he echocardiographic examinations were exclusively performed
y two experienced echocardiographers. Echocardiographic mea-
urements performed at rest included transvalvular flow velocity,
ressure gradient, and velocity time integral (VTI) using continuous-
ave Doppler. Pulsed-wave Doppler was used for the measurements
n the left ventricular outflow tract (LVOT). LVOT diameter was
ssessed from a parasternal long-axis view using an expanded (zoom)
iew. The same measurements were performed during exercise, ex-
ept for LVOT diameter, which was assumed to remain constant.10
he mean systolic pressure gradient was calculated as the difference
f mean aortic and mean LVOT gradient.
The EOA was calculated by using the continuity equation:
OA [cm2]
 (LVOT diameter [cm] 0.5)2   VTILVOT ⁄ VTIvalve
The effective orifice area index (EOAI [cm2/m2]) was calcu-
ated by dividing the EOA by body surface area (DuBois
ormula).11
The EOF3 was used to compare the different valve types. This
s the relation of Doppler-derived EOA to the anatomic annulus
rea measured intraoperatively.
EOF  Doppler-derived EOA [cm2]/anatomic annulus area
cm2].
xercise Protocol
uring bicycle exercise (Ergoline, ergometrics er900EL, Bitz,
ermany), patients sat reclined in a 50-degree position. After the
atients started exercise with a workload of 25 Watts, the workload
as increased by 25 Watts every 2 minutes. The patients were
ncouraged to exercise until exhaustion. In case of unsatisfactory
oppler signals, the whole bicycle unit was tilted to the left side
ntil optimal measurements were obtained. Measurements were
erformed at the end of each 2-minute workload level. Blood
ressure was measured every 2 minutes using a sphygmomanom-
ABLE 1. Patients’ characteristics at the time of operation
Perimount (Edwards
Lifesciences, Irvine, Calif)
Magna (
Lifesci
o. of patients 50 7
ge at implant (y) 75.2 6.1 74.2
ange 60.1-87.8 55.2
ender M/F (% M) 13/37 (26) 24/46
nnulus diameter (mm) 21.90 1.20 21.46
SA (m2) 1.75 0.20 1.76
SA, Body surface area.
ABLE 2. Reasons for nonattendance at the follow-up exa
Perim
o hemodynamic data could be obtained after 6 mo n  20
atient’s death n  1
efusal to attend follow-up n  15
ad sonic conditions n  4
236 The Journal of Thoracic and Cardiovascular Surgery ● Mater cuff fixed on the right arm. A 12-lead electrocardiogram was
ontinuously recorded. Exercising was stopped by the investigator
n case of hypertension (blood pressure  210/110 mm Hg),
lectrocardiogram changes as ST segment abnormalities, new ar-
hythmias (atrial fibrillation, premature ventricular complexes as
ouplets, bigemini, or trigemini), tachycardia with more than 120
eats/min, angina pectoris, or severe dyspnea.
atient–Prosthesis Mismatch
ccording to Blais and colleagues,12 patient–prosthesis mismatch
PPM) was defined as severe if the prosthetic aortic valve EOAI
as 0.65 cm2/m2 or less, as moderate if EOAI was greater than
.65 cm2/m2 and 0.85 cm2/m2 or less, and as clinically not signif-
cant if EOAI was greater than 0.85 cm2/m2. To calculate the rate
f PPM, the body surface area and the Doppler-derived EOA were
ssessed 6 months postoperatively in every individual patient.
OAs for the prosthetic valves that are available in the literature or
rovided by the manufacturers were not used for reference.
tatistical Analysis
tatistical analysis was performed with the Statistical Package for
he Social Sciences 14.0 for Windows (SPSS Inc, Chicago, Ill).
ontinuous data are presented as mean  standard deviation. To
ompare categoric data, the chi-square test was used. To compare
ontinuous data in more than 2 groups, the Kruskal–Wallis test
as used. To detect differences between groups, analysis of vari-
nce with Bonferroni correction for multiple testing was applied.
esults
emodynamic Results
ean systolic pressure gradients and stroke volumes are
hown in Figure 1. Gradients increased with every exercise
evel because of larger stroke volumes. The pericardial
alves showed lower gradients compared with the porcine
rds
)
Mosaic (Medtronic Inc,
Minneapolis, Minn)
Soprano (Sorin Group,
Saluggi, Italy) P
44 28
75.9 5.6 73.9  6.1 .705
65.6-89.4 61.1-83.6
13/31 (30) 13/15 (46) .297
9 21.61 1.15 21.39 1.34 .298
9 1.74 0.16 1.78  0.16 .703
tion 6 months postoperatively
Magna Mosaic Soprano
%) n  15 (21.4%) n  12 (27.3%) n  3 (10.7%)
n  3 n  1 n  0
n  10 n  6 n  3Edwa
ences
0
6.2
-84.9
(34)
1.4
0.1mina
ount
(40.0n  2 n  5 n  0
y 2007
vg
s
T
c
s
S
T
a
T
N
A
R
G
A
B
B
Wagner et al Surgery for Acquired Cardiovascular Disease
A
CDalve (P  .05). In addition, the Magna showed lower
radients than did the Soprano and Perimount (P  .05).
The mean EOFs of the 4 valves assessed in this study are
hown in Figure 2.
The mean EOAs and mean EOAIs are summarized in
able 4. The Mosaic had a significantly lower EOA and EOAI
ABLE 3. Characteristics of patients who underwent stres
Perimount Mag
o. of patients 29 2
ge at implant (y) 76.15 6.35 74.98
ange 60.1-87.8 63.2-
ender M/F (% M) 9/20 (31) 12/14
nnulus diameter (mm) 21.93 1.16 21.81
SA (m2) 1.78 0.20 1.81
SA, Body surface area.The Journal of Thoracicompared with those of the 3 other valves (P .05), whereas no
ignificant difference could be shown between the other valves.
izing Results
he individual intraoperatively measured annulus size (Hegar)
nd the labeled size for each valve are shown in Table 5.
Figure 1. Mean systolic pressure gra-
dients and stroke volumes at rest and
during exercise.
hocardiography
Mosaic Soprano P
32 16
8 75.30 5.57 73.39 5.85 .427
65.6-89.4 61.1-83.6
11/21 (34) 7/9 (44) .689
3 21.69 1.03 21.25 1.24 .266
2 1.77 0.22 1.74 0.15 .702s ec
na
6
6.0
84.9
(46)
1.3
0.2and Cardiovascular Surgery ● Volume 133, Number 5 1237
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CDatient–Prosthesis Mismatch
igure 3 shows the incidence of PPM in the 4 groups. Six
onths postoperatively, the incidence of severe PPM in the
agna (3/55) and Soprano (1/25) groups was low. In con-
rast, 53% of the patients (16/30) in the Perimount group
nd 69% of the patients (22/32) in the Mosaic group showed
oderate or severe PPM.
xercise Testing
xercise testing was performed in 106 of 142 patients. The
easons why patients could not perform exercise testing
ere orthopedic ailments (back, hip, knee pain) (n  27),
eripheral arterial occlusive disease (n  2), disability
aused by hemiplegia (n 2), New York Heart Association
unctional class III (n 3), hypertension at rest (n 2), and
efusal (n  3). Because of bad sonic conditions in 3
atients, data during exercise could not be obtained. Termi-
ation by the investigator because of the reasons mentioned
n the “Methods” section was necessary in 16 patients.
leven patients continued up to 100 Watts. Twenty-six
atients stopped exercising because of peripheral pain, 4
atients stopped because of peripheral arterial occlusive
isease, and the others stopped because of arthrosis-related
nee or hip pain. Twelve patients terminated exercising
ecause of leg muscle weakness, and 16 patients terminated
igure 2. EOF, the independent index for valve performance, of
he stented bioprostheses as percentages in the diagram. The
ean EOAs (inner black circle) in relation to the annulus areas
outer white circle). EOA, effective orifice area.
ABLE 4. Doppler-derived effective orifice area and effect
Perimount
OA cm2 1.59 0.41 1.6
OAI cm2/m2 0.90 0.25 0.9
o significant differences among Perimount, Magna, and Soprano valves fo
alves versus Mosaic valve (P  .05) for EOA and EOAI. EOA, Effective orifice
238 The Journal of Thoracic and Cardiovascular Surgery ● Maxercising because of peripheral exhaustion. Twenty-five
atients stopped exercising because of cardiopulmonary
xhaustion.
iscussion
emodynamic Performance
he systolic hemodynamic performance of the 3 bovine
rostheses (Soprano, Magna, and Perimount) and the por-
ine (Mosaic) bioprosthesis corresponded to the outcome of
ther reports on these prosthetic heart valves.6,8,13-17
Up to now there has been no direct in vivo comparison
etween the 3 bovine valves and the porcine valve at rest
nd during exercise. Assessment of hemodynamic variables
uring exercise may be more appropriate to study the per-
ormance of the valves,18 because it reflects more closely
he situation in daily life.
Compared with the other prostheses, the Magna showed
he lowest gradients at rest and during exercise. All 3
ericardial valves exhibited lower gradients compared with
he porcine valve. We are aware that the measurement of
radients does not entirely represent the complex function
f a valve. For this reason we think that in vitro studies (eg,
erosa and associates19) performed with the same valves
re absolutely necessary and complete our in vivo find-
ngs to describe variables such as stroke work loss, total
egurgitant, and leakage volumes for the individual
rostheses.
In most patients, stroke volume increases during mild
xercise. Because of systolic or diastolic dysfunction, mitral
alve disease, or elevated afterload and peripheral vascular
esistance, the increase of stroke volume may be impaired,
specially in elder patients. This could be an explanation for
he missing increase of stroke volume at the 75-Watt level
n the patients with the Perimount valve.
omparison of Different Valve Types
he hemodynamic comparison of different prostheses is
omplicated by the fact that the labeled valve size does not
eflect the same dimensions for each prosthesis and thus is
ot suitable as a basis for valve comparisons. Prostheses
arrying the same labeled valve size may have a different
ffect on blood flow according to their individual geometric
imensions.1,20 To correct for these differences in valve
esign, comparisons should be based on the EOF as an
ndependent index of valve performance.3
rifice area index 6 months postoperatively
a Mosaic Soprano
0.38 1.31 0.42 1.64  0.32
0.22 0.75 0.24 0.92  0.15
and EOAI; significant differences among Perimount, Magna, and Sopranoive o
Magn
4
3
r EOA
area; EOAI, effective orifice area index.
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A
CDIn our series the pericardial valves showed a larger EOF
ompared with the porcine valve. Although the completely
upra-annular design should result in an optimized func-
ional use of the anatomically given annulus area, the
ntra–supra-annular Perimount shows lower mean pressure
radients than the Mosaic and Soprano and no significant
ifference in EOF compared with the completely supra-
nnular Soprano and Magna. In an in vitro study, Gerosa
nd colleagues19 compared 3 pericardial bioprostheses
Perimount Magna, Sorin Soprano, and Sorin Mitroflow)
nd 2 porcine bioprostheses (St Jude Medical Epic Supra [St
ude Medical Inc, St Paul, Minn] and Medtronic Mosaic) by
sing a pulse duplicator. Accordant to our findings, the
ericardial valves showed lower pressure gradients and
arger EOAs than those of the porcine valves. The authors
ake into account that a meaningful hemodynamic compar-
son of different valve types should not be based on indus-
ry-labeled valve sizes by comparing prostheses that can fit
n a 21-mm pulse duplicator ring regardless of industry-
abeled valve size. In vivo, the decision that leads to the
election of a certain valve size is additionally influenced by
he complex anatomic structure of the aortic root in com-
ination with prosthesis dimensions, including stent height,
ewing ring diameter, completely supra-annular position,
nd anatomic relation to the coronary ostia (Figure 4).
atient–Prosthesis Mismatch
lthough the clinical impact of PPM after aortic valve
eplacement is still considered to be controversial, there is
vidence that PPM might lead to higher rates of cardiac
orbidity and mortality.12,21-23 For the 4 valve types stud-
ed, we demonstrated differences in the rates of PPM as
ABLE 5. Individual intraoperatively measured annulus dia
Valve label n 17 mm 18 mm
erimount 19 4
21 24
23 21
25 1
agna 19 8 1 1
21 32
23 29
25 1
osaic 19 3 1
21 19
23 22
25
oprano 18 3 1
20 16
22 8
24 1efined by Blais and colleagues,12 calculated with the Dop- P
The Journal of Thoracicler-derived EOAI 6 months postoperatively. This gradua-
ion corresponds to the assumption that moderate aortic
tenosis of a native valve is present if EOAI is less than 0.90
m2/m2.24 There is general agreement that the only param-
ter to define PPM is the relation of EOA to the patient’s
ody surface area, but there is still no general agreement on
ow to calculate the prosthesis EOA.
In our opinion the EOA of an implanted valve is a
unctional parameter that probably depends on leaflet com-
liance, orientation, and position (angle) in relation to the
VOT and the ascending aorta. Thus, the EOA has to be
ssessed for every individual patient and his/her valve sub-
titute. The easiest way to determine the EOA of an im-
lanted valve is Doppler echocardiography with the use of
igure 3. Incidence of PPM calculated with the Doppler-derived EOA
months postoperatively. severe PPM moderate PPM□ no PPM.
ers and the corresponding labeled valve sizes
Annulus diameter (Hegar measurement)
19 mm 20 mm 21 mm 22 mm 23 mm
2 2
3 11 7 3
3 18
1
4 2
11 17 4
1 2 26
1
2
5 7 7
2 10 10
1 1
1 2 7 3 3
5 3
1metPM, Patient–prosthesis mismatch; EOA, effective orifice area.
and Cardiovascular Surgery ● Volume 133, Number 5 1239
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A
CDydrodynamic principles (continuity equation). However,
ecause the Doppler-derived EOA depends on various he-
odynamic conditions, it should not be determined just in
he early postoperative period when patients may be still
nemic; left ventricular function may not yet have been
estored, and volume status may be disordered. In the
resent study, EOA and the occurrence of PPM were as-
essed 6 months postoperatively by means of Doppler EOA
easurement. According to a literature survey by Pibarot
nd colleagues,25 PPM is present in up to 20% to 70% of
atients with a stented aortic bioprosthesis. In our series
PM ranged from 32% (Soprano) to 69% (Mosaic).
ompletely Supra-annular Design
he new generation of stented bioprostheses for completely
upra-annular placement is represented by the Magna, Mo-
aic, and Soprano valves in our series. This technical de-
elopment aims at optimizing the systolic hemodynamic
erformance of any stented prosthesis. The EOF, which
epresents the use of the anatomically given annulus area,
anged from 35.2% (Mosaic) to 45.8% (Soprano) in our
igure 4. Two aortic root anatomies with an identical TAD. A
ore bulbar-shaped root (right). This is the ideal situation for
ompletely supra-annular placement in which the tissue annulus
iameter corresponds to the internal orifice diameter of the
rosthesis (TAD  IOD). Small aortic root (left). Despite the same
issue annular diameter, the valve of the same size (black) does
ot fit. Thus, the surgeon has to choose a smaller valve (white),
ith the consequence that despite implantation of a completely
upra-annular prosthesis, the stent and sewing ring material
mpair the bloodstream because the shape of the aortic root does
ot allow the implantation of a valve large enough to ensure that
he IOD corresponds to the TAD. This illustrates the hypothesis
hat a completely supra-annular prosthesis placement does not
nsure a hemodynamic benefit in every aortic root. Even after
mplantation of a completely supra-annular prosthesis, flow ob-
truction caused by the stent and sewing ring material may
ccur if there is a narrow aortic root. TAD, Tissue annulus
iameter; IOD, internal orifice diameter; ESRD, external sew-
ng ring diameter.eries. This reveals that despite the completely supra-annu-
240 The Journal of Thoracic and Cardiovascular Surgery ● Maar design, the whole annulus area is not available for blood
ow, presumably because the stent and sewing ring material
re still positioned within the blood flow. Thus, the com-
letely supra-annular design does not necessarily lead to
uperior hemodynamic results compared with the intra–
upra-annular valve. Presumably, not every aortic root is
natomically suitable to exhibit the advantages of the com-
letely supra-annular design. In a very straight aortic root,
ith little extension of the sinuses, even the completely
upra-annular valve protrudes somewhat into the outflow
ract. Figure 4 illustrates our hypothesis that even if a
ompletely supra-annular prosthesis is used, flow obstruc-
ion caused by the stent and sewing ring material cannot
lways be avoided.
imitations
ecause our study was a nonrandomized study, bias result-
ng from patient and valve selection by the implanting
urgeon cannot be excluded.
The hemodynamic performance of aortic valve substi-
utes depends on a number of cofactors, such as left ven-
ricular systolic and diastolic function, the patient’s volume
tatus, function of the mitral valve, blood pressure, heart
ate, and so forth, which were not analyzed in this study.
For various reasons, not all patients were able to reach
igher exercise levels. Therefore, the hemodynamic data
hat are available for comparison at 75 Watts are scarce
Figure 1).
The result of echocardiography may be influenced by the
onic conditions that differ from patient to patient and may
herefore be biased.
onclusions
he 4 bioprostheses compared in this study showed satis-
actory hemodynamic results at rest and during exercise in
atients with a small aortic annulus. Completely supra-
nnular valves were designed to minimize the flow obstacle
hat is caused by the sewing ring and stent material reaching
nto the annulus diameter. We demonstrated that this con-
ept does not necessarily lead to superior hemodynamic
esults, which we believe may depend on the anatomy of the
ortic root. The pericardial, completely supra-annular
agna bioprosthesis with a reduced sewing ring indicated
he lowest pressure gradients at rest and during exercise and
eems to deal best with the challenge of achieving good
emodynamics in patients with a small aortic annulus,
hich is often associated with a narrow ascending aorta.
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